Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
37%

OVERLAP
BY WEIGHT
13

# OF OVERLAPPING
HOLDINGS
MEDX
28
HOLDINGS
46%
ALSO IN FTXH
FTXH
51
HOLDINGS
27%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus FTXH)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in FTXH
Overlap
ABBVIE INC 9.4% 7.6% 7.6%
JOHNSON & JOHNSON 5.0% 7.6% 5.0%
BRISTOL-MYERS SQUIBB CO 3.9% 6.4% 3.9%
ELI LILLY & CO 14.4% 3.8% 3.8%
AMGEN INC 3.8% 3.6% 3.6%
MEDX Overweight Relative to FTXH
ELI LILLY & CO 10.6%
NOVARTIS AG-ADR 6.7%
ALNYLAM PHARMACEUTICALS INC 5.9%
ASTRAZENECA PLC-SPONS ADR 5.2%
IONIS PHARMACEUTICALS, INC. 4.1%
CRISPR THERAPEUTICS AG 3.9%
ALKERMES PLC 2.8%
GLAXOSMITHKLINE PLC-SPON ADR 2.6%
INTELLIA THERAPEUTICS, INC. 1.9%
ABBVIE INC 1.8%
MEDX Underweight Relative to FTXH
MERCK & CO. INC. -4.0%
GILEAD SCIENCES INC -3.8%
VERTEX PHARMACEUTICALS INC -3.7%
CARDINAL HEALTH INC -3.7%
PFIZER INC -3.5%
UNITED THERAPEUTICS CORP -3.4%
ZOETIS INC -3.2%
VIATRIS, INC. -3.2%
JOHNSON & JOHNSON -2.6%
BRISTOL-MYERS SQUIBB CO -2.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY